Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Neos Therapeutics Cmn (NEOS)

7.25 -0.15 (-2.03%)

6/23/2017  4:00pm

Open:

7.30

Pre. Close:

7.40

High:

7.50

Low:

6.91

Volume:

1,193,557

Market Cap:

163.56M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

7.58 - 7.76

7.76 - 7.93

Low:

6.53 - 6.68

6.68 - 6.82

Close:

7.06 - 7.29

7.29 - 7.52

Technical analysis  (as of: 2017-06-23 4:36:53 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 10.01     One year: 11.21

Support:

Support1: 6.91    Support2: 5.75

Resistance:

Resistance1: 8.57    Resistance2: 9.60

Pivot:

8.09

Moving Averages:

MA(5): 7.79     MA(20): 8.12

MA(100): 7.00     MA(250): 7.15

MACD:

MACD(12,26): -0.01     Signal(12,26,9): 0.14

%K %D:

%K(14,3): 11.82     %D(3): 23.91

RSI:

RSI(14): 41.42

52-Week:

High: 9.99  Low: 4.85  Change(%): -24.9

Average Vol(K):

3-Month: 416  10-Days 1087

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
NEOS has closed above bottom band by 10.0%. Bollinger Bands are 57.8% wider than normal. The large width of the bands suggest high volatility as compared to NEOS's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Tue, 20 Jun 2017 01:41:15 GMT
Neos Therapeutics Announces FDA Approval of Cotempla XR-ODT™ (methylphenidate ...

Tue, 30 May 2017 11:30:31 GMT
Neos Therapeutics to Present at Jefferies 2017 Global Healthcare Conference

Tue, 20 Jun 2017 16:18:45 GMT
Neos Therapeutics Slides Despite FDA Approval

Tue, 20 Jun 2017 16:07:30 GMT
Analytical Guide for two rising stock's: Neos Therapeutics, Inc. (NEOS ...

Wed, 21 Jun 2017 10:30:00 GMT
Neos Therapeutics, Inc. (NEOS) has just broken below 20DMA

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

22.56

Shares Float (M)

13.11

% Held by Insiders

9.62

% Held by Institutions

2.10

Shares Short (K)

2610

Shares Short Prior Month (K)

2590

Stock Financials

EPS

-5.180

EPS Est. Current Year

-3.230

EPS Est. Next Year

-1.510

EPS Est. Next Quarter

-0.850

Forward EPS

-1.509

Book Value (p.s.)

0.560

PEG Ratio

-0.03

Profit Margin

Operating Margin

-651.73

Return on Assets (ttm)

-45.8

Return on Equity (ttm)

-222.1

Qtrly Rev. Growth

117.8

Gross Profit (p.s.)

-0.101

Sales Per Share

EBITDA (p.s.)

-3.418

Qtrly Earnings Growth

Operating Cash Flow (M)

-73.61

Levered Free Cash Flow (M)

-50.47

FoxReading.com

Valuation

P/E

-1.40

P/E Growth Ratio

-0.02

P/BV

12.95

P/S

227166672.00

P/CF

-2.22

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.